Search Results - "Hamilton, D. A."

Refine Results
  1. 1

    Behavioral flexibility in rats and mice: contributions of distinct frontocortical regions by Hamilton, D. A., Brigman, J. L.

    Published in Genes, brain and behavior (01-01-2015)
    “…Research examining the contribution of genetics to behavior is increasingly focused on higher order behavioral and cognitive processes including the ability to…”
    Get full text
    Journal Article
  2. 2

    Antipsychotic drug effects in schizophrenia: a review of longitudinal FMRI investigations and neural interpretations by Abbott, C C, Jaramillo, A, Wilcox, C E, Hamilton, D A

    Published in Current medicinal chemistry (2013)
    “…The evidence that antipsychotics improve brain function and reduce symptoms in schizophrenia is unmistakable, but how antipsychotics change brain function is…”
    Get more information
    Journal Article
  3. 3
  4. 4
  5. 5

    The gelation of CO2 : A sustainable route to the creation of microcellular materials by SHI, C, HUANG, Z, KILIC, S, XU, J, ENICK, R. M, BECKMAN, E. J, CARR, A. J, MELENDEZ, R. E, HAMILTON, A. D

    “…Compounds with strong thermodynamic affinity for carbon dioxide have been designed and synthesized that dissolve in CO2, then associate to form gels. Upon…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Farnesyltransferase and geranylgeranyltransferase I inhibitors upregulate RhoB expression by HDAC1 dissociation, HAT association and histone acetylation of the RhoB promoter by DELARUE, F. L, ADNANE, J, CHELLAPPAN, S, SEBTI, S. M, JOSHI, B, BLASKOVICH, M. A, WANG, D.-A, HAWKER, J, BIZOUARN, F, OHKANDA, J, ZHU, K, HAMILTON, A. D

    Published in Oncogene (01-02-2007)
    “…Recently, we have shown that RhoB suppresses EGFR-, ErbB2-, Ras- and Akt-mediated malignant transformation and metastasis. In this paper, we demonstrate that…”
    Get full text
    Journal Article
  8. 8

    The farnesyl transferase inhibitor, FTI-277, inhibits growth and induces apoptosis in drug-resistant myeloma tumor cells by BOLICK, S. C. E, LANDOWSKIL, T. H, BOULWARE, D, OSHIRO, M. M, OHKANDA, J, HAMILTON, A. D, SEBTI, S. M, DALTON, W. S

    Published in Leukemia (01-02-2003)
    “…Mutations of the ras gene are among the most commonly identified transforming events in human cancers, including multiple myeloma. Farnesyltransferase…”
    Get full text
    Journal Article
  9. 9
  10. 10

    BCL2 gene abnormalities define distinct clinical subsets of follicular lymphoma by Goodlad, J R, Batstone, P J, Hamilton, D A, Kernohan, N M, Levison, D A, White, J M

    Published in Histopathology (01-09-2006)
    “…Aims:  Follicular lymphoma (FL) arising primarily in the skin has recently been proposed as a distinct entity on the basis of a low incidence of…”
    Get full text
    Journal Article
  11. 11

    Genetic responses to climate in Pinus contorta: niche breadth, climate change, and reforestation by Rehfeldt, Gerald E., Ying, Cheng C., Spittlehouse, David L., Hamilton, David A.

    Published in Ecological monographs (01-08-1999)
    “…Fundamental plant-environment relationships were revealed by analyses of 20-yr height and survival of 118 populations representing two subspecies of Pinus…”
    Get full text
    Journal Article
  12. 12

    Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts by SUN, J, YIMIN QIAN, HAMILTON, A. D, SEBTI, S. M

    Published in Oncogene (01-03-1998)
    “…The ability of Ras oncoproteins to cause malignant transformation requires their post-translational modifications by prenyl groups. Because K-Ras can be both…”
    Get full text
    Journal Article
  13. 13

    Thermodynamic Aspects of Dicarboxylate Recognition by Simple Artificial Receptors by Linton, Brian R, Goodman, M. Scott, Fan, Erkang, van Arman, Scott A, Hamilton, Andrew D

    Published in Journal of organic chemistry (02-11-2001)
    “…Recognition of dicarboxylates by bis-functional hydrogen-bonding receptors displays divergent thermodynamics in different solvent systems. NMR titration and…”
    Get full text
    Journal Article
  14. 14

    Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines by LERNER, E. C, ZHANG, T.-T, KNOWLES, D. B, QIAN, Y, HAMILTON, A. D, SEBTI, S. M

    Published in Oncogene (01-09-1997)
    “…The farnesyltransferase (FTase) inhibitor FTI-277 is highly effective at blocking oncogenic H-Ras but not K-Ras4B processing and signaling. While inhibition of…”
    Get full text
    Journal Article
  15. 15

    Inhibiting ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenes by BERNHARD, E. J, MCKENNA, W. G, HAMILTON, A. D, SEBTI, S. M, YIMIN QIAN, JUNMIN WU, MUSCHEL, R. J

    Published in Cancer research (Chicago, Ill.) (15-04-1998)
    “…The influence of activated ras oncogenes on the sensitivity of human tumor cells to killing by radiation has been an unresolved question in radiobiology. We…”
    Get full text
    Journal Article
  16. 16

    The differential expression of a heat shock promoter in floral and reproductive tissues by Crone, D., Rueda, J., Martin, K. L., Hamilton, D. A., Mascarenhas, J. P.

    Published in Plant, cell and environment (01-08-2001)
    “…A detailed histochemical analysis of the expression of the soybean small heat shock protein gene promoter, GmHSP 17·5E, fused to the GUS reporter gene, has…”
    Get full text
    Journal Article
  17. 17

    Ras CAAX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-Ras mutation and p53 deletion by JIAZHI SUN, YIMIN QIAN, HAMILTON, A. D, SEBTI, S. M

    Published in Cancer research (Chicago, Ill.) (01-10-1995)
    “…Farnesylation of the oncoprotein Ras is required for its cancer-causing activity. We have designed farnesyltransferase inhibitor (FTI)-276, a tetrapeptide…”
    Get full text
    Journal Article
  18. 18

    The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts by BERNHARD, E. J, KAO, G, COX, A. D, SEBTI, S. M, HAMILTON, A. D, MUSCHEL, R. J, MCKENNA, W. G

    Published in Cancer research (Chicago, Ill.) (15-04-1996)
    “…Many tumor cells have a greater resistance to ionizing radiation than their normal counterparts, suggesting that the development of drugs that can reduce that…”
    Get full text
    Journal Article
  19. 19

    Potent, Highly Selective, and Non-Thiol Inhibitors of Protein Geranylgeranyltransferase-I by Vasudevan, Anil, Qian, Yimin, Vogt, Andreas, Blaskovich, Michelle A, Ohkanda, Junko, Sebti, Said M, Hamilton, Andrew D

    Published in Journal of medicinal chemistry (22-04-1999)
    “…The design, synthesis, and biological evaluation of a family of peptidomimetic inhibitors of protein geranylgeranyltransferase-I (PGGTase-I) are reported. The…”
    Get full text
    Journal Article
  20. 20

    Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issues by Sebti, S M, Hamilton, A D

    Published in Expert opinion on investigational drugs (01-12-2000)
    “…The fact that proteins such as Ras, Rac and RhoA require farnesylation or geranylgeranylation to induce malignant transformation prompted many investigators to…”
    Get more information
    Journal Article